针对长新冠生活的个性化自我管理干预的有效性与成本效果:LISTEN随机对照试验方案
LISTEN试验是一项实用性随机对照试验,计划纳入558名非住院长新冠患者,随机分配至LISTEN共同设计的个性化自我管理支持干预组或常规照护组,评估对日常活动参与、社会参与、情绪健康、生活质量、疲劳和自我效能的影响及成本效果,并在随机化后6周和3个月(主要终点)完成自我报告结局测量。
要点
- LISTEN试验评估共同设计的个性化自我管理支持干预对非住院长新冠患者的效果与成本效果。
- 计划随机纳入558名非住院长新冠患者,干预组接受最多六次一对一课程及共同设计的数字资源和纸质手册。
- 主要终点为随机化后3个月,同时在6周和3个月收集自我报告结局,并开展详细过程评价。
核心结论
- LISTEN试验旨在评估共同设计的个性化自我管理支持干预对非住院长新冠患者在常规活动参与、社会参与、情绪健康、生活质量、疲劳和自我效能方面的效果及成本效果。
研究设计与样本
- 实用性随机有效性与成本效果试验,计划将558名非住院长新冠患者随机分配至LISTEN干预组或常规照护组。
- 招募策略由LISTEN患者与公众参与及 Engagement(PPIE)顾问组和社会企业Diversity and Ability参与制定以确保包容性,合格参与者可通过网站自行转介或由长新冠服务机构转介。
- 所有参与者在基线、随机化后6周和3个月(试验主要终点)在线完成一系列自我报告结局测量。
- 随机分配至LISTEN干预组的参与者接受最多六次与接受LISTEN培训的干预执行者的一对一课程,并获得共同设计的数字资源和纸质手册。
- 与试验同步开展详细过程评价,以便在LISTEN干预被证明有效且具有成本效果时为实施方法提供信息。
局限性
- 随访持续时间有限,所有参与者均被征询同意长期随访(取决于能否获得额外资金)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Individuals living with long COVID experience multiple, interacting and fluctuating symptoms which can have a dramatic impact on daily living. The aim of the Long Covid Personalised Self-managemenT support EvaluatioN (LISTEN) trial is to evaluate effects of the LISTEN co-designed self-management support intervention for non-hospitalised people living with long COVID on participation in routine activities, social participation, emotional well-being, quality of life, fatigue, and self-efficacy. Cost-effectiveness will also be evaluated, and a detailed process evaluation carried out to understand how LISTEN is implemented. METHODS: The study is a pragmatic randomised effectiveness and cost-effectiveness trial in which a total of 558 non-hospitalised people with long COVID will be randomised to either the LISTEN intervention or usual care. Recruitment strategies have been developed with input from the LISTEN Patient and Public Involvement and Engagement (PPIE) advisory group and a social enterprise, Diversity and Ability, to ensure inclusivity. Eligible participants can self-refer into the trial via a website or be referred by long COVID services. All participants complete a range of self-reported outcome measures, online, at baseline, 6 weeks, and 3 months post randomisation (the trial primary end point). Those randomised to the LISTEN intervention are offered up to six one-to-one sessions with LISTEN-trained intervention practitioners and given a co-designed digital resource and paper-based book. A detailed process evaluation will be conducted alongside the trial to inform implementation approaches should the LISTEN intervention be found effective and cost-effective. DISCUSSION: The LISTEN trial is evaluating a co-designed, personalised self-management support intervention (the LISTEN intervention) for non-hospitalised people living with long COVID. The design has incorporated extensive strategies to minimise participant burden and maximise access. Whilst the duration of follow-up is limited, all participants are approached to consent for long-term follow-up (subject to additional funding being secured). TRIAL REGISTRATION: LISTEN ISRCTN36407216. Registered on 27/01/2022.
引用
- Potter C, Leggat F, Lowe R, et al. Effectiveness and cost-effectiveness of a personalised self-management intervention for living with long COVID: protocol for the LISTEN randomised controlled trial. Trials. 2023. PMID: 36726167. doi:10.1186/s13063-023-07090-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。